Anew Health Limited (AVG)
| Market Cap | 259.00M |
| Revenue | 41.32M +49.6% |
| Net Income | 9.76M +122.1% |
| EPS | 0.19 |
| Shares Out | 51.80M |
| PE Ratio | 26.54 |
| Forward PE | 18.75 |
| Dividend | $0.07 (1.14%) |
| Ex-Dividend Date | May 29, 2025 |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 24, 2025 |
About AVG
Anew Health is a Hong Kong-based pain management and health services provider with over 16 years of experience in pain management and functional enhancement, under our “ANKH” brand. We offer a broad range of non-surgical, non-invasive, and non-pharmacological pain management treatment and therapies, functional enhancement therapies, and topical use and dietary supplements health products, to our clients to eliminate pain points, invigorate blood circulation, enhance the body’s detoxification function, strengthen muscle and joint, and ultimately... [Read more]
Financial Performance
Financial StatementsNews
Hong Kong health services provider Anew Health files and sets terms for a $20 million US IPO
Anew Health, a Hong Kong-based pain management and health services provider, filed on Friday with the SEC to raise up to $20 million in an initial public offering.
Anew Health IPO Registration Document (F-1)
Anew Health has filed to go public with an IPO on the NASDAQ.